Technology area: Biotechnology & Pharmaceuticals
16 pending office actions • 10 art units • 16 examiners • 0 of 16 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
Mary Kay Inc. has 16 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 16 examiners across 10 art units, showing broad examiner distribution within a more limited set of technical groups. Art-unit coordination may help organize recurring technical issues, but the examiner assignments require individualized response analysis.
CHHAY, BONIRATH is the busiest examiner, with 1 pending matter. Counsel should preserve consistent scientific terminology and disclosure positions while tailoring claim strategy to each examiner and record. The profile does not show a repeated examiner relationship that would support a concentrated prosecution approach.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (12%) |
| §103 only | 7 (44%) |
| Double-patenting + other | 5 (31%) |
| Multi-statute (no §101) | 2 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHHAY, BONIRATH | 1 | 62.5% | +0.0% |
| ATKINSON, JOSHUA ALEXANDER | 1 | 51.8% | +27.5% |
| BOATENG, AFUA BAMFOAA | 1 | 46.7% | +64.5% |
| PHAN, DOAN THI-THUC | 1 | 42.8% | +47.6% |
| STEINKE, SEAN JAMES | 1 | 12.5% | +42.9% |
| WRIGHT, SARAH C | 1 | 42.1% | +45.6% |
| PEEBLES, KATHERINE | 1 | 35.6% | +48.0% |
| HARRIS, BRITTANY SHARON | 1 | 48.7% | +35.4% |
| JUSTICE, GINA CHIEUN YU | 1 | 55.6% | +8.5% |
| LEWIS, PATRICK T | 1 | 74.0% | +14.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19234482 | METHOD FOR DETERMINING FACIAL MUSCLE RESPONSES | CHHAY, BONIRATH | — |
| 18891671 | METHOD AND COMPOSITIONS FOR COSMETIC COMPOSITIONS | STEINKE, SEAN JAMES | — |
| 18763400 | METHODS AND COMPOSITIONS FOR ULTRAVIOLET PROTECTION OF SKIN | PEEBLES, KATHERINE | — |
| 18680001 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | LEWIS, PATRICK T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19109343 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | ATKINSON, JOSHUA ALEXANDER | — |
| 19000308 | COSMETIC COMPOSITIONS AND METHODS OF USING SAME | BOATENG, AFUA BAMFOAA | — |
| 18899566 | SKIN LIGHTENING COMPOSITIONS | PHAN, DOAN THI-THUC | — |
| 18891671 | METHOD AND COMPOSITIONS FOR COSMETIC COMPOSITIONS | STEINKE, SEAN JAMES | — |
| 18792230 | TOPICAL COMPOSITIONS | WRIGHT, SARAH C | — |
| 18763400 | METHODS AND COMPOSITIONS FOR ULTRAVIOLET PROTECTION OF SKIN | PEEBLES, KATHERINE | — |
| 18758807 | HIGH SEPARATION DUAL PHASE EYE MAKE-UP REMOVER | HARRIS, BRITTANY SHARON | — |
| 18680001 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | LEWIS, PATRICK T | — |
| Art Unit | Apps |
|---|---|
| 1612 | 3 |
| 1617 | 3 |
| 1619 | 2 |
| 1616 | 2 |
| 1645 | 1 |
| 1613 | 1 |
| 1761 | 1 |
| 1691 | 1 |
| 1655 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19234482 | METHOD FOR DETERMINING FACIAL MUSCLE RESPONSES | CHHAY, BONIRATH | 1645 | §101§103§112DP | Non-Final OA | — | Pending | Jun 11, 2025 |
| 19109343 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | ATKINSON, JOSHUA ALEXANDER | 1612 | §102§103§112DP | Non-Final OA | — | Pending | Mar 06, 2025 |
| 19000308 | COSMETIC COMPOSITIONS AND METHODS OF USING SAME | BOATENG, AFUA BAMFOAA | 1617 | §103 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18899566 | SKIN LIGHTENING COMPOSITIONS | PHAN, DOAN THI-THUC | 1613 | §103§112DP | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18891671 | METHOD AND COMPOSITIONS FOR COSMETIC COMPOSITIONS | STEINKE, SEAN JAMES | 1619 | §101§103§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18792230 | TOPICAL COMPOSITIONS | WRIGHT, SARAH C | 1619 | §103 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18763400 | METHODS AND COMPOSITIONS FOR ULTRAVIOLET PROTECTION OF SKIN | PEEBLES, KATHERINE | 1617 | §102§103§112 | Final Rejection | — | Pending | Jul 03, 2024 |
| 18758807 | HIGH SEPARATION DUAL PHASE EYE MAKE-UP REMOVER | HARRIS, BRITTANY SHARON | 1761 | §103 | Final Rejection | — | Pending | Jun 28, 2024 |
| 18745158 | TOPICAL MUSCLE RELAXATION COMPOSITIONS AND METHODS | JUSTICE, GINA CHIEUN YU | 1617 | §103 | Final Rejection | 17d overdue | Pending | Jun 17, 2024 |
| 18680001 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | LEWIS, PATRICK T | 1691 | §102§103§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18674250 | MASCARA FORMULATION | PACKARD, BENJAMIN J | 1612 | §103Other | Non-Final OA | — | Pending | May 24, 2024 |
| 18664854 | SKIN CARE FORMULATION | BOECKELMAN, JACOB A | 1655 | §103 | Final Rejection | 40d | Pending | May 15, 2024 |
| 18387319 | PORE MINIMIZER | ABRAHAM, AMJAD A | 1663 | §103§112DP | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18500625 | COSMETIC COMPOSITIONS AND USES THEREOF | VIGIL, TORIANA NICHOLE | 1612 | §103 | Non-Final OA | 9d overdue | Pending | Nov 02, 2023 |
| 18347025 | COSMETIC COMPOSITION | HAGOPIAN, CASEY SHEA | 1616 | §103§112DP | Non-Final OA | — | Pending | Jul 05, 2023 |
| 18133271 | SKIN CLEANSER COMPOSITIONS AND METHODS FOR USE | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103DP | Non-Final OA | — | Pending | Apr 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMary Kay Inc. has 16 pending office actions as of October 2026, spread across 10 art units and 16 examiners.
Bonirath Chhay has the most, with 1 of Mary Kay Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
